This is the authors' abstract. We don't add key points for this paper.
Recently novel metal-based nanoclusters have gained growing attention regarding their biomedical applications owing to the remarkable characteristics, such as ultrasmall size, luminescence, catalytic properties, reduced poisonousness, and excellent bio-compatibility. However, the use of metal-based nanoclusters in brain research and in different brain disorders has not yet been widely studied. This review summarize the most recent developments concerning the application of novel metal-based nanoclusters with blood–brain barrier permeability for the diagnosis and treatment of brain disorders. We mainly discuss the use of metal-based nanoclusters for fluorescent biological imaging or in the diagnosis of brain disorders, the enhanced brain tumor-suppressing efficacy of the metal-based nanocluster sensitizer, and their potential for treating brain diseases. Furthermore, the challenges to their possible biomedical applications are also discussed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: